Related News
AIDS gel with Gilead drug protects women in study
Source: Agencies |
July 20, 2010, Tuesday
|
Online Edition
Online Edition
AA GEL made using Gilead Sciences Inc's HIV drug tenofovir reduced HIV infections in women by 39 percent over two and a half years -- the first time such an approach has protected against the virus, South African researchers reported today.
In addition, the gel reduced the risk a woman would get genital herpes by 51 percent, a surprise finding that adds further benefits, Dr. Salim Abdool Karim at the University of KwaZulu-Natal in Durban, South Africa said in results to be released at the International AIDS Conference in Vienna.
In addition, the gel reduced the risk a woman would get genital herpes by 51 percent, a surprise finding that adds further benefits, Dr. Salim Abdool Karim at the University of KwaZulu-Natal in Durban, South Africa said in results to be released at the International AIDS Conference in Vienna.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
